| Issue Date | Title | Author(s) |
| 2020-08-03 | COVID-19: The Immune Responses and Clinical Therapy Candidates. | Zhand, S; Saghaeian Jazi, M; Mohammadi, S; Tarighati Rasekhi, R; Rostamian, G; Kalani, MR; Rostamian, A; George, J; Douglas, MW |
| 2021-09 | Advanced therapeutic modalities in hepatocellular carcinoma: Novel insights. | Shokoohian, B; Negahdari, B; Aboulkheyr Es, H; Abedi-Valugerdi, M; Baghaei, K; Agarwal, T; Maiti, TK; Hassan, M; Najimi, M; Vosough, M |
| 2021-07-19 | The Pandora’s Box of novel technologies that may revolutionize lung cancer | Rad, HS; Rad, HS; Shiravand, Y; Radfar, P; Arpon, D; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021-01-01 | Understanding the tumor microenvironment for effective immunotherapy. | Sadeghi Rad, H; Monkman, J; Warkiani, ME; Ladwa, R; O'Byrne, K; Rezaei, N; Kulasinghe, A |
| 2018 | Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology. | Valdes-Mora, F; Handler, K; Law, AMK; Salomon, R; Oakes, SR; Ormandy, CJ; Gallego-Ortega, D |
| 2023-02 | Immunotherapeutic targets in non-small cell lung cancer. | Sadeghirad, H; Bahrami, T; Layeghi, SM; Yousefi, H; Rezaei, M; Hosseini-Fard, SR; Radfar, P; Warkiani, ME; O'Byrne, K; Kulasinghe, A |
| 2021 | Emerging role of circulating tumor cells in immunotherapy. | Rzhevskiy, A; Kapitannikova, A; Malinina, P; Volovetsky, A; Aboulkheyr Es, H; Kulasinghe, A; Thiery, JP; Maslennikova, A; Zvyagin, AV; Ebrahimi Warkiani, M |
| 2017-04 | The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy. | Law, AMK; Lim, E; Ormandy, CJ; Gallego-Ortega, D |
| 2023-01 | Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma. | Pourhamzeh, M; Asadian, S; Mirzaei, H; Minaei, A; Shahriari, E; Shpichka, A; Es, HA; Timashev, P; Hassan, M; Vosough, M |
| 2023 | Compartmentalized spatial profiling of the tumor microenvironment in head and neck squamous cell carcinoma identifies immune checkpoint molecules and tumor necrosis factor receptor superfamily members as biomarkers of response to immunotherapy. | Sadeghirad, H; Liu, N; Monkman, J; Ma, N; Cheikh, BB; Jhaveri, N; Tan, CW; Warkiani, ME; Adams, MN; Nguyen, Q; Ladwa, R; Braubach, O; O'Byrne, K; Davis, M; Hughes, BGM; Kulasinghe, A |
